Jerrold Frank Rosenbaum MD

Dr. Jerrold Rosenbaum, psychiatrist-in-chief at the Massachusetts General Hospital and Stanley Cobb Professor of Psychiatry at Harvard Medical School, is recognized as one of the world’s authorities on mood and anxiety disorders, with a special emphasis on pharmacotherapy of those conditions.

His research contributions include extensive leadership in the development of new therapies, the design and implementation of trials to develop innovative treatments for major depression, treatment-resistant depression, and panic disorder, studies of psychopathology, including comorbidity and subtypes, and studies of longitudinal course and outcomes of those disorders.Dr. Rosenbaum has authored more than 400 original articles and reviews and has authored or edited 20 books. He serves on 12 editorial boards of professional journals or newsletters.

A particular research focus has been ongoing studies of children at risk for anxiety disorders and depression, which examine behavioral differences, risk factors, longitudinal outcomes, treatment, genetics, and brain structure and function of children of parents with mood and anxiety disorders.At Mass General, Dr. Rosenbaum directs a department of more than 600 clinicians, researchers, and trainees, named by U.S. News and World Report as the #1 Department of Psychiatry in the United States for 17 of the last 20 years.

Also at Mass General – the largest hospital based research institution in the world, with over 800 million dollars per year of research funding – he has served as chair of the hospital’s Executive Committee on Research.His clinical and consulting practice specializes in treatment-resistant mood and anxiety disorders, and he consults extensively to colleagues on management of these conditions.